🩺 Now Hiring: Psychiatric Nurse Practitioner (PMHNP) · $70/hr · Part-Time · Canton, Baltimore — View the Role & Apply →
Off-Label · Anesthesiologist-Led · Baltimore MD · LegitScript Certified

Ketamine for Anxiety Disorders
in Baltimore

When SSRIs, SNRIs, and therapy haven't produced adequate relief — a different mechanism

Ketamine for anxiety Baltimore costs $499.99 per session ($375 for Vitality Circle members) and is off-label IV ketamine infusion therapy evaluated when first-line treatments haven't been enough — delivered as anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD, a Johns Hopkins anesthesiologist, with a Certified Registered Nurse Anesthetist (CRNA) on-site. Three presentations are assessed: generalized anxiety disorder (GAD), social anxiety disorder, and panic disorder — when SSRIs, SNRIs, and an adequate course of CBT have not produced adequate relief; because anxiety so often co-occurs with depression, that is reviewed alongside it. Ketamine works through a different mechanism than those medications: NMDA receptor blockade in the brain's fear circuits, with anxiolytic effects that may appear within hours to days, not weeks. The evidence base is promising but smaller than for depression. All anxiety use is off-label and self-pay, with an itemized superbill you can file with your insurance.

5.0·103 Google reviews

"The team is extremely professional, compassionate and knowledgeable — they take the time to explain the process thoroughly and care about your well-being throughout." — Google review, Vita Nova patient

GAD · Social Anxiety · Panic Disorder Off-Label · 2+ Prior Trials Required From $375/Session (Members) Results in Hours — Not Weeks Self-Pay · Superbill Provided
Ketamine therapy for anxiety disorders at Vita Nova Ketamine and Wellness Clinic, 513 Bayview Blvd Canton Baltimore MD — off-label infusions for GAD, social anxiety and panic disorder
Ketamine therapy for anxiety disorders — Vita Nova · 513 Bayview Blvd, Canton, Baltimore MD 21224 · Off-label · Anesthesiologist-led
BJ
Medical Director
Dr. Brijen L. Joshi, MD
Reviewed August 2026

Founder & Medical Director, Vita Nova · Johns Hopkins Faculty Physician · Assistant Professor, Anesthesiology & Critical Care Medicine · Chief, Thoracic Anesthesia, Johns Hopkins Hospital · Board-Certified Anesthesiologist

🛡️ LegitScript Certified 🏥 Johns Hopkins
Start Your Evaluation
If two or more SSRIs or SNRIs and therapy haven't produced adequate relief, ketamine may be appropriate. A telemedicine consultation is the first step — your provider reviews your full history and determines whether a care pathway is appropriate. No commitment required.
Book Telemedicine Consultation → View Self-Pay Pricing
LegitScript Certified — Vita Nova Ketamine & Wellness Clinic BusinessRate Best Mental Health Clinic Baltimore 2026 — Vita Nova
🏥 Johns Hopkins Faculty MD
💵 HSA / FSA · Self-Pay · Superbills
🦅 Community Heroes Discounts

Mon–Fri: 1PM–8PM · Sat: 10AM–2PM
513 Bayview Blvd, Canton, Baltimore MD 21224
(443) 563-1059

Anxiety & Ketamine at a Glance
1
Three anxiety presentations evaluated: GAD, social anxiety disorder, and panic disorder — when SSRIs, SNRIs, and therapy have not produced adequate relief. All care is anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD, a Johns Hopkins faculty anesthesiologist, with a CRNA on-site
2
Off-label for all anxiety indications — IV ketamine is not FDA-approved for anxiety. Prescribed based on physician clinical judgment and published evidence
3
Different mechanism: NMDA blockade in fear circuits — amygdala, prefrontal cortex, anterior cingulate — distinct from SSRIs (serotonin) and benzodiazepines (GABA)
4
Rapid onset: in responders, anxiolytic effects may appear within hours to days — contrasting with the 4–8 week onset of SSRIs and SNRIs
5
Pricing: $499.99/session non-member · $375/session Vitality Circle member · Complete Series of 6 infusions $2,250 (members) with 3 complimentary hydration IVs included. Self-pay with an itemized superbill · HSA / FSA accepted
6
Community Heroes discounts for veterans, first responders, teachers, nurses, and seniors — anxiety disorders are highly prevalent in these populations
Free · No Commitment · 2 Minutes
Not Ready to Book?
Tell Us About Your Situation

Answer a few quick questions — our clinical team reaches out within 1 business day to discuss whether ketamine therapy may be right for you.

Your information is confidential. A clinical team member follows up within 1 business day.

01
Conditions Evaluated

Three Anxiety Presentations Vita Nova Evaluates

Anxiety disorders are the most prevalent mental health conditions in the United States — affecting an estimated 31% of adults at some point in their lives. The three presentations evaluated at Vita Nova for ketamine therapy are those in which standard first-line treatments have been insufficient.

🌀
Generalized Anxiety Disorder (GAD)
ICD-10: F41.1

GAD is characterized by persistent, excessive, and difficult-to-control worry about multiple domains — health, finances, relationships, work — that is disproportionate to actual risk and causes significant impairment. First-line treatments include SSRIs (escitalopram, sertraline), SNRIs (duloxetine, venlafaxine), buspirone, and CBT. Ketamine is evaluated at Vita Nova when two or more adequate pharmacological trials and an adequate course of CBT have not produced adequate relief.

Core Symptoms
  • Persistent, uncontrollable worry across multiple life domains
  • Restlessness or feeling on edge
  • Fatigue and difficulty concentrating
  • Muscle tension and sleep disruption
  • Irritability
👥
Social Anxiety Disorder
ICD-10: F40.10

Social anxiety disorder is a marked and persistent fear of social or performance situations involving scrutiny or humiliation — leading to significant avoidance or distress. Standard first-line treatments include SSRIs (paroxetine, sertraline), SNRIs (venlafaxine), and CBT with exposure components. Ketamine is evaluated when functional impairment remains significant despite adequate prior treatment attempts.

Core Symptoms
  • Intense fear of social situations involving scrutiny or judgment
  • Avoidance of social, occupational, or academic situations
  • Physical symptoms: flushing, sweating, trembling, nausea
  • Significant functional impairment in relationships or career
Panic Disorder
ICD-10: F41.0

Panic disorder involves recurrent, unexpected panic attacks followed by persistent concern about future attacks and significant behavioral change. First-line treatments include SSRIs (sertraline, fluoxetine), SNRIs, benzodiazepines (short-term), and CBT with interoceptive exposure. Ketamine is evaluated when panic disorder remains inadequately controlled despite prior first-line approaches.

Core Symptoms
  • Recurrent unexpected panic attacks — racing heart, shortness of breath, chest pain, dizziness
  • Persistent worry about future attacks and their consequences
  • Significant behavior change to avoid triggering attacks
  • Agoraphobia may develop as avoidance generalizes
02
Why Ketamine May Work for Anxiety

The Mechanism — NMDA & Fear Circuit Restoration

Anxiety disorders involve chronic dysregulation of fear circuits — the amygdala, prefrontal cortex, anterior cingulate cortex, and hippocampus — resulting in exaggerated threat detection and persistent fear responses. Ketamine's NMDA-blocking mechanism engages these circuits directly.

💊
SSRIs / SNRIs / Benzodiazepines
  • SSRIs/SNRIs modulate serotonin and norepinephrine — indirect effect on fear circuits via monoamine pathways. Require 4–8 weeks of daily dosing. Do not directly address glutamatergic dysregulation
  • Benzodiazepines enhance GABA activity — rapid anxiolysis but tolerance and dependence risk. No lasting circuit-level change. High-dose benzodiazepines can blunt ketamine's therapeutic effect
  • Neither class directly targets the structural and functional impairments in prefrontal regulatory circuits that underlie chronic anxiety
Ketamine — NMDA Blockade
  • Blocks NMDA receptors in the amygdala and prefrontal cortex — directly dampening glutamatergic hyperactivity that maintains chronic fear circuit overdrive
  • Promotes rapid synaptogenesis in the medial prefrontal cortex — potentially restoring top-down inhibitory control over amygdala threat responses
  • Anxiolytic effects may appear within hours to days — contrasting with the 4–8 week onset of SSRIs and SNRIs
  • Circuit-level changes may persist beyond the active dosing period, unlike benzodiazepines which produce only acute symptomatic suppression

References: Glue P et al. (2017). J Psychopharmacol. PMID 28441895 · Glue P et al. (2018), maintenance study. J Psychopharmacol. PMID 29561204 · Taylor JH et al. (2018). Neuropsychopharmacology. PMID 28849779.

03
Clinical Evidence

The Research Behind Ketamine for Anxiety

The evidence base for ketamine in anxiety disorders is less developed than for treatment-resistant depression or PTSD — but growing, and the mechanistic rationale is strong.

Dose-Response Study · 2017
Glue et al. — Journal of Psychopharmacology
Open-label study of repeated IV ketamine infusions in patients with treatment-refractory GAD and social anxiety disorder. Significant dose-related reductions in anxiety symptom severity were observed, with effects apparent within hours of infusion. Response was sustained over the multi-infusion course.
PMID 28441895 · J Psychopharmacol, 2017
Double-Blind Replication · 2020
Glue et al. — Journal of Psychopharmacology
Double-blind, psychoactive-controlled ascending-dose replication of the 2017 findings in 12 patients with treatment-refractory GAD and social anxiety disorder, confirming dose-related anxiolytic effects of IV ketamine. The blinded, active-comparator design provided stronger evidence for a specific pharmacological anxiolytic action.
PMID 31526207 · J Psychopharmacol, 2020
Placebo-Controlled RCT · 2018
Taylor et al. — Neuropsychopharmacology
Double-blind, randomized, placebo-controlled crossover trial of a single IV ketamine infusion in 18 adults with social anxiety disorder. Ketamine produced significantly greater reduction in clinician-rated social anxiety than placebo in the days after infusion, while self-rated anxiety did not separate — an honest, mixed proof-of-concept result that supports larger trials.
PMID 28849779 · Neuropsychopharmacology, 2018
Context Note
Evidence Maturity vs. Depression and PTSD
The anxiety evidence base is earlier-stage than for treatment-resistant depression or PTSD. Most anxiety-specific ketamine studies are open-label or small controlled trials. Larger definitive trials are underway. The mechanistic rationale is strong; the clinical evidence is promising but not yet at the level of depression.
ClinicalTrials.gov — multiple active studies

Important: Ketamine for anxiety disorders is off-label. The evidence base is promising but earlier-stage than for treatment-resistant depression. Individual results vary significantly. A comprehensive clinical evaluation is required before any recommendation is made at Vita Nova.

04
Pricing

Cost at Vita Nova Baltimore

Ketamine for anxiety is off-label, and ketamine at Vita Nova is self-pay — you pay directly, and we provide an itemized superbill you can file with your insurance. HSA and FSA cards are accepted for the full cost, and Vitality Circle membership brings the per-session rate down. Each session is delivered as anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD — a Johns Hopkins faculty physician — in a private treatment room with continuous monitoring and individualized dosing, so the price reflects physician-level, monitored care, not a walk-in vitamin drip. The Complete Series lowers the effective per-session cost and adds 3 complimentary hydration IVs.

TreatmentNon-MemberVitality Circle MemberSaving
Ketamine Infusion — per session Off-Label$499.99$375$124.99/session
Complete Series — 6 infusions +3 complimentary hydration IVs$2,849.94$2,250$599.94

Self-pay, with a superbill. Vita Nova is self-pay for ketamine. We provide an itemized superbill you can file with your insurance. HSA and FSA accepted; Community Heroes discounts available. Sessions determined individually. Pricing August 2026 — subject to change. Full pricing guide →

05
Supportive Wellness

Complementary Treatments Alongside Ketamine for Anxiety

Chronic anxiety is associated with magnesium depletion, B-vitamin deficiency, iron-deficiency anemia, elevated cortisol, and mitochondrial energy dysregulation. The following wellness services at Vita Nova address these factors.

🧘
Magnesium IM Shot
$49.99 · Included for members

Magnesium modulates NMDA receptor sensitivity — directly relevant to ketamine's anxiety mechanism. Deficiency is associated with heightened anxiety, sleep disruption, and muscle tension. IM delivery bypasses poor absorption and GI intolerance of oral magnesium.

✅ Included for Vitality Circle members (2 shots/month)
🔋
B-Complex Shot
$49.99 · Included for members

Chronic anxiety depletes B-vitamin reserves — particularly B1, B6, and B5, which support GABAergic and serotonergic neurotransmission. IM delivery achieves immediate bioavailability of the full B-vitamin spectrum.

✅ Included for Vitality Circle members (2 shots/month)
🩸
Iron IV Therapy
Members discounted · Confirmed deficiency only

Iron-deficiency anemia can produce or amplify physical symptoms that overlap with anxiety — heart palpitations, restlessness, fatigue, and shortness of breath — and is easily mistaken for worsening anxiety, especially in menstruating women. Iron does not treat an anxiety disorder, but when labs confirm deficiency, an Iron IV restores stores faster than oral iron. Ask about ferritin testing if physical symptoms persist.

Members: discounted pricing
☀️
Vitamin D3 Shot
$49.99 · Included for members

Vitamin D3 deficiency is strongly associated with anxiety and mood disorders. Baltimore's northern latitude makes seasonal deficiency common. IM delivery achieves therapeutic levels more reliably than oral D3 in deficient patients.

✅ Included for Vitality Circle members (2 shots/month)
NAD+ IV Therapy
$374.99–$999.99 · Members 25% off

Chronic anxiety is metabolically expensive — sustained hyperarousal depletes cellular energy and NAD+ reserves. IV NAD+ supports mitochondrial function and neurological restoration, addressing physiological exhaustion from long-standing anxiety.

Members: 25% off all doses

Clinical note: These wellness services are not treatments for anxiety disorders and are not part of Vita Nova's ketamine clinical protocols. They are general wellness support addressing physiological factors. Always discuss with your treating physician before adding supplemental therapy alongside any care pathway.

06
Community Heroes Program

Special Pricing for Those Who Serve

Anxiety disorders are disproportionately prevalent among veterans, first responders, healthcare workers, and teachers. The Community Heroes program ensures cost is not the barrier that prevents access to a care pathway that standard treatments have failed to provide.

🦅 Community Heroes Discount Program · Vita Nova Baltimore
Special Pricing for Those Who Have Served
Eligibility and specific discount amounts are confirmed at the time of booking. Call (443) 563-1059 or submit the Community Heroes form to apply.
🎖️
Veterans & Active-Duty
🚒
Police · Fire · EMS
🚑
EMTs & Paramedics
🏥
Nurses & Healthcare
🍎
Teachers & Educators
🌟
Seniors 65+
07
Frequently Asked Questions

Anxiety & Ketamine — Questions Answered

Common questions from patients evaluating ketamine therapy for anxiety disorders in Baltimore.

Ketamine infusions for anxiety disorders in Baltimore cost $499.99 per session for non-members and $375 per session for Vitality Circle members. The Complete Series of 6 infusions is $2,849.94 (or $2,250 for members) and includes 3 complimentary hydration IVs. Every session is delivered as anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD. Ketamine for anxiety is off-label and self-pay — Vita Nova provides an itemized superbill you can file with your insurance. HSA and FSA are accepted, and Community Heroes discounts are available for veterans, first responders, teachers, nurses, and seniors. See the full pricing guide or verify your benefits free (reply in 1–2 business days).
Ketamine has shown rapid anxiolytic effects in clinical studies, though the evidence base for anxiety is earlier-stage than for treatment-resistant depression. Glue et al. (2017, PMID 28441895) found significant, dose-related anxiety reduction in patients with treatment-refractory GAD and social anxiety disorder after repeated IV ketamine infusions, with effects appearing within hours; a 2020 double-blind replication study (PMID 31526207) confirmed the anxiolytic effect, and a 2018 placebo-controlled trial in social anxiety (PMID 28849779) showed a clinician-rated benefit. Ketamine for anxiety is off-label, results vary by individual, and it is evaluated only when SSRIs, SNRIs, and CBT haven't produced adequate relief. A comprehensive clinical evaluation is required at Vita Nova, 513 Bayview Blvd, Canton, Baltimore MD 21224.
No. Ketamine infusions for anxiety disorders are off-label — not FDA-approved for GAD, social anxiety disorder, panic disorder, or any other anxiety indication. Off-label prescribing is a legal and standard medical practice when a licensed physician determines it clinically appropriate based on peer-reviewed evidence and individual assessment. Prescribing at Vita Nova is grounded in clinical judgment and published anxiety-specific ketamine research, and every patient is screened for suitability and contraindications before any care pathway is offered.
Ketamine's proposed anxiolytic mechanism involves NMDA receptor blockade in fear circuits — particularly the amygdala, medial prefrontal cortex, and anterior cingulate cortex — that are consistently hyperactive in anxiety disorders. By blocking NMDA receptors, ketamine dampens glutamatergic hyperactivity in these circuits. It simultaneously promotes rapid synaptogenesis in prefrontal regions, potentially restoring top-down inhibitory regulation of the amygdala's exaggerated threat responses. These mechanisms are distinct from SSRIs (serotonin) and benzodiazepines (GABA), explaining why ketamine may be effective when those approaches have not produced adequate relief. Anxiolytic effects may appear within hours, contrasting with the 4–8 week onset of SSRIs.
Often within hours to days — much faster than SSRIs and SNRIs, which typically need 4–8 weeks. In the Glue studies, anxiety reductions appeared within hours of an infusion and built over a multi-infusion course. That speed is one of the main reasons ketamine is considered when first-line medications have been too slow or insufficient. The trade-off is durability: a single infusion's effect tends to fade, so ketamine is delivered as a short induction series, with maintenance spaced to hold the response. Response and durability vary from person to person, and ketamine for anxiety remains off-label.
Vita Nova evaluates three anxiety presentations for off-label ketamine therapy on an individual basis: generalized anxiety disorder (GAD) that has not responded to two or more adequate SSRI or SNRI trials and an adequate course of CBT; social anxiety disorder with significant functional impairment despite first-line treatment; and panic disorder that remains inadequately controlled despite prior pharmacological and psychological approaches. Not every patient is a candidate — an individual clinical evaluation is required at 513 Bayview Blvd, Canton, Baltimore MD 21224.
High-dose benzodiazepines are the most significant medication interaction concern for ketamine therapy. They enhance GABA activity in a way that directly opposes the glutamatergic mechanism through which ketamine produces its therapeutic effects — blunting the NMDA-blocking response and potentially reducing clinical benefit. This is particularly relevant for anxiety patients, for whom benzodiazepines are often part of the existing treatment regimen. Your provider reviews your complete medication list during the clinical evaluation and will discuss whether and how to adjust benzodiazepine use before beginning ketamine therapy. Any adjustments are made only in coordination with your existing prescribing physician.
Cognitive-behavioral therapy (CBT) is the gold-standard first-line talk therapy for all three anxiety disorders evaluated at Vita Nova — with the strongest evidence base. CBT works through cognitive restructuring and graduated exposure. Ketamine is evaluated as a pharmacological option for patients who have not achieved adequate response from established first-line approaches including SSRIs, SNRIs, and CBT. Ketamine is not a replacement for therapy — some patients pursue ketamine alongside continued work with their existing therapist. Vita Nova encourages care coordination with existing therapeutic providers during the evaluation process.
Sometimes. Iron-deficiency anemia can produce or amplify physical sensations that closely overlap with anxiety — heart palpitations, restlessness, shortness of breath, fatigue, and poor concentration — and it's easy to mistake for worsening anxiety, especially in menstruating women, postpartum patients, and people with restricted diets. Iron does not treat an anxiety disorder, and low iron is not the cause of a true anxiety disorder — but when bloodwork confirms deficiency, correcting it can remove a physical driver that's making symptoms feel worse. An Iron IV infusion restores stores faster than oral iron when labs confirm deficiency. Ask your provider about checking ferritin and a CBC if physical symptoms persist.
GAD · Social Anxiety · Panic Disorder · Baltimore MD

If First-Line Treatments
Haven't Been Enough —

A different mechanism may reach what SSRIs, SNRIs, and therapy could not. Start with a telemedicine consultation — your provider reviews your full history and determines whether a care pathway is appropriate. All care anesthesiologist-led, under the medical direction of Dr. Brijen Joshi MD. Self-pay with an itemized superbill. Community Heroes discounts available.

📍 513 Bayview Blvd · Canton, Baltimore MD 21224  ·  🅿️ Free Parking
Mon–Fri: 1PM–8PM · Sat: 10AM–2PM · (443) 563-1059

Canonical URL: https://vitanovawellnessclinic.com/ketamine-anxiety-baltimore/  ·  Last reviewed August 2026

Medically reviewed by Dr. Brijen L. Joshi MD — Assistant Professor of Anesthesiology & Critical Care Medicine, Johns Hopkins University School of Medicine · Chief of Thoracic Anesthesia, Johns Hopkins Hospital · Medical Director, Vita Nova Ketamine & Wellness Clinic.  ·  View full team →

Medical Disclaimer: Ketamine infusion therapy for anxiety disorders is off-label — not FDA-approved for GAD, social anxiety disorder, panic disorder, or any anxiety indication. Off-label prescribing is a legal and standard medical practice when determined clinically appropriate by a licensed physician. Individual eligibility requires a comprehensive clinical evaluation — not all patients are candidates and not all patients who complete evaluation are offered a care pathway. Individual results vary. This page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Please review our Side Effects & Risk Disclosures and Informed Consent pages before scheduling care. In a mental health crisis, call or text 988.